Menu
GeneBe

PEX10

peroxisomal biogenesis factor 10, the group of Peroxins|Ring finger proteins

Basic information

Region (hg38): 1:2403963-2413797

Links

ENSG00000157911NCBI:5192OMIM:602859HGNC:8851Uniprot:O60683AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • peroxisome biogenesis disorder 6A (Zellweger) (Definitive), mode of inheritance: AR
  • peroxisome biogenesis disorder 6B (Moderate), mode of inheritance: AR
  • peroxisome biogenesis disorder 6A (Zellweger) (Strong), mode of inheritance: AR
  • peroxisome biogenesis disorder 6A (Zellweger) (Definitive), mode of inheritance: AR
  • Zellweger spectrum disorders (Supportive), mode of inheritance: AR
  • autosomal recessive ataxia due to PEX10 deficiency (Supportive), mode of inheritance: AR
  • peroxisome biogenesis disorder 6B (Definitive), mode of inheritance: AR
  • peroxisome biogenesis disorder 6B (Strong), mode of inheritance: AR
  • peroxisome biogenesis disorder (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Peroxisome biogenesis disorder 6A (Zellweger syndrome); Peroxisome biogenesis disorder 6BARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Renal9700193; 9683594; 12794690; 10862081; 17041890; 19127411; 20695019

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PEX10 gene.

  • Peroxisome biogenesis disorder, complementation group 7 (587 variants)
  • Peroxisome biogenesis disorder 6A (Zellweger) (125 variants)
  • not provided (111 variants)
  • Zellweger spectrum disorders (83 variants)
  • Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B (41 variants)
  • Inborn genetic diseases (26 variants)
  • Peroxisome biogenesis disorder 6B (17 variants)
  • not specified (14 variants)
  • Peroxisome biogenesis disorder (13 variants)
  • Peroxisome biogenesis disorder 6B;Peroxisome biogenesis disorder 6A (Zellweger) (10 variants)
  • PEX10-related condition (4 variants)
  • Peroxisome biogenesis disorder 1A (Zellweger) (2 variants)
  • Spastic ataxia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PEX10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
178
clinvar
4
clinvar
184
missense
1
clinvar
1
clinvar
228
clinvar
2
clinvar
2
clinvar
234
nonsense
9
clinvar
12
clinvar
21
start loss
4
clinvar
1
clinvar
5
frameshift
34
clinvar
32
clinvar
66
inframe indel
6
clinvar
6
splice donor/acceptor (+/-2bp)
1
clinvar
13
clinvar
14
splice region
6
16
1
23
non coding
1
clinvar
36
clinvar
67
clinvar
11
clinvar
115
Total 49 60 272 247 17

Highest pathogenic variant AF is 0.0000788

Variants in PEX10

This is a list of pathogenic ClinVar variants found in the PEX10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-2404815-C-G Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)876385
1-2404861-T-G Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)876386
1-2404912-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296252
1-2404928-G-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296253
1-2404931-G-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296254
1-2404942-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)874434
1-2404968-G-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296255
1-2404984-G-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)296256
1-2405021-G-GC Peroxisome biogenesis disorder 1A (Zellweger) Uncertain significance (Jun 14, 2016)296257
1-2405034-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296258
1-2405078-C-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296259
1-2405080-G-C Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)875341
1-2405090-G-A Peroxisome biogenesis disorder 6A (Zellweger) Likely benign (Jan 13, 2018)875342
1-2405123-G-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)875343
1-2405139-G-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296260
1-2405171-C-T Peroxisome biogenesis disorder 6A (Zellweger) Benign/Likely benign (Jan 01, 2023)875344
1-2405172-G-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296261
1-2405267-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)296262
1-2405321-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 22, 2018)875345
1-2405346-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296263
1-2405356-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)296264
1-2405365-T-G Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 13, 2018)875398
1-2405414-C-T Peroxisome biogenesis disorder 6A (Zellweger) Benign (Jan 13, 2018)296265
1-2405456-C-T Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)296266
1-2405462-G-A Peroxisome biogenesis disorder 6A (Zellweger) Uncertain significance (Jan 12, 2018)296267

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PEX10protein_codingprotein_codingENST00000288774 69001
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0005420.9751256800491257290.000195
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2942292171.060.00001522142
Missense in Polyphen6069.3730.86489762
Synonymous0.01169696.10.9990.00000624759
Loss of Function1.99816.80.4779.93e-7157

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004810.000474
Ashkenazi Jewish0.0001020.0000993
East Asian0.0002940.000272
Finnish0.000.00
European (Non-Finnish)0.0002350.000229
Middle Eastern0.0002940.000272
South Asian0.0002030.000196
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Somewhat implicated in the biogenesis of peroxisomes.;
Disease
DISEASE: Peroxisome biogenesis disorder complementation group 7 (PBD-CG7) [MIM:614870]: A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). {ECO:0000269|PubMed:19105186}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peroxisome biogenesis disorder 6A (PBD6A) [MIM:614870]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and clinically characterized by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269|PubMed:9700193}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peroxisome biogenesis disorder 6B (PBD6B) [MIM:614871]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. {ECO:0000269|PubMed:9683594}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Peroxisome - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Peroxisomal protein import;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins (Consensus)

Recessive Scores

pRec
0.165

Intolerance Scores

loftool
0.234
rvis_EVS
-0.27
rvis_percentile_EVS
34.82

Haploinsufficiency Scores

pHI
0.104
hipred
N
hipred_score
0.390
ghis
0.546

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.876

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pex10
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
protein targeting to peroxisome;peroxisome organization;protein import into peroxisome matrix;protein ubiquitination
Cellular component
peroxisome;peroxisomal membrane;integral component of peroxisomal membrane
Molecular function
protein binding;zinc ion binding